VVY Vivoryon Therapeutics N.V.

1.100EUR0.00%Mkt Cap: 35.41M $P/E: —

Vivoryon Therapeutics N.V. operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-…